DK0525502T4 - Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger - Google Patents

Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger

Info

Publication number
DK0525502T4
DK0525502T4 DK92111947T DK92111947T DK0525502T4 DK 0525502 T4 DK0525502 T4 DK 0525502T4 DK 92111947 T DK92111947 T DK 92111947T DK 92111947 T DK92111947 T DK 92111947T DK 0525502 T4 DK0525502 T4 DK 0525502T4
Authority
DK
Denmark
Prior art keywords
preparation
virus inactivated
immunoglobulin solutions
inactivated immunoglobulin
solutions
Prior art date
Application number
DK92111947T
Other languages
Danish (da)
English (en)
Other versions
DK0525502T3 (da
Inventor
Werner Gehringer
Patrick Selosse
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6437560&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0525502(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK0525502T3 publication Critical patent/DK0525502T3/da
Publication of DK0525502T4 publication Critical patent/DK0525502T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92111947T 1991-08-02 1992-07-14 Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger DK0525502T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4125625A DE4125625C2 (de) 1991-08-02 1991-08-02 Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen

Publications (2)

Publication Number Publication Date
DK0525502T3 DK0525502T3 (da) 1997-03-17
DK0525502T4 true DK0525502T4 (da) 2005-09-19

Family

ID=6437560

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92111947T DK0525502T4 (da) 1991-08-02 1992-07-14 Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinoplösninger

Country Status (14)

Country Link
US (1) US5648472A (cs)
EP (1) EP0525502B2 (cs)
JP (1) JP2969310B2 (cs)
KR (1) KR100188448B1 (cs)
AT (1) ATE143812T1 (cs)
CZ (1) CZ291813B6 (cs)
DE (2) DE4125625C2 (cs)
DK (1) DK0525502T4 (cs)
ES (1) ES2092604T5 (cs)
FI (1) FI107122B (cs)
IL (1) IL102525A (cs)
SK (1) SK280680B6 (cs)
YU (1) YU48242B (cs)
ZA (1) ZA925764B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4424935C1 (de) * 1994-07-14 1996-03-21 Immuno Ag Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung
US6136865A (en) * 1995-05-20 2000-10-24 Octapharma Ag Method for reduction of the infectiousness of potentially infectious material
AT403477B (de) * 1996-04-30 1998-02-25 Immuno Ag Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
IL121900A (en) * 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
PT911037E (pt) † 1997-10-23 2002-12-31 Mitsubishi Pharma Corp Preparacao de imunoglobulina armazenavel a temperatura ambiente para injeccao intravenosa
DE10016877A1 (de) * 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung
IL136552A (en) 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
US8541399B2 (en) 2002-02-19 2013-09-24 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals
ATE428730T1 (de) * 2003-08-12 2009-05-15 Octapharma Ag Verfahren zur herstellung einer alpha-1- antitrypsinlösung
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
EP1718675B2 (en) 2004-02-27 2017-01-25 Octapharma AG A method of providing a purified, virus safe antibody preparation
RU2352358C1 (ru) * 2007-10-04 2009-04-20 Наталия Васильевна Зубкова Способ приготовления вирусинактивированных растворов иммуноглобулинов
FR2944281B1 (fr) * 2009-04-08 2011-07-29 Fabre Pierre Dermo Cosmetique Derives soufres de resorcinol, leur preparation et leurs utilisations cosmetiques
CN111108193A (zh) 2017-09-18 2020-05-05 拜耳医药保健有限公司 使用n-甲基葡糖酰胺及其衍生物灭活病毒的方法
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4481189A (en) * 1982-04-14 1984-11-06 New York Blood Center Inc. Process for preparing sterilized plasma and plasma derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography

Also Published As

Publication number Publication date
SK236992A3 (en) 1995-01-12
DE59207324D1 (de) 1996-11-14
EP0525502A1 (de) 1993-02-03
EP0525502B2 (de) 2005-08-10
CZ291813B6 (cs) 2003-06-18
JP2969310B2 (ja) 1999-11-02
ZA925764B (en) 1993-04-28
ATE143812T1 (de) 1996-10-15
FI107122B (fi) 2001-06-15
US5648472A (en) 1997-07-15
DE4125625A1 (de) 1993-02-04
SK280680B6 (sk) 2000-06-12
CZ236992A3 (en) 1993-02-17
EP0525502B1 (de) 1996-10-09
IL102525A (en) 2005-05-17
YU74092A (sh) 1995-10-24
DK0525502T3 (da) 1997-03-17
ES2092604T3 (es) 1996-12-01
ES2092604T5 (es) 2006-03-01
YU48242B (sh) 1997-08-22
IL102525A0 (en) 1993-01-14
DE4125625C2 (de) 1999-12-02
FI923425L (fi) 1993-02-03
FI923425A0 (fi) 1992-07-29
JPH05202100A (ja) 1993-08-10
KR930004329A (ko) 1993-03-22
KR100188448B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
DK0525502T3 (da) Fremgangsmåde til fremstilling af virusinaktiverede immunoglobulinopløsninger
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
EP0128522A3 (en) High titer cytomegalovirus immune serum globulin and method of making same
EP0029063A4 (en) DETERMINATION OF THE NON-A, NON-B HEPATITIS ANTIGENS.
HU9301794D0 (en) Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament
DK422589A (da) Farmaceutisk praeparat til behandling af immundefekttilstande
EP0593290A3 (en) Core antigen protein of the hepatitis C virus, as well as diagnostic procedure and set of reagents.
AU4233585A (en) Vaccine against rabies and preparation process thereof
EP0590460A3 (de) Hochkonzentrierte wässrige Poly(acrylnitril)-Emulsionen und Verfahren zu ihrer Herstellung.
PT625204E (pt) Terapeutica da hepatite
BR0010815A (pt) Método de preparação de globulina imune duplamente inativada viralmente para administração intravenosa
FI915813A0 (fi) Menetelmä luonnollisesti tuotetun kymosiinin talteenottamiseksi
ATE193287T1 (de) Herstellung von derivaten von a-acetyl neuraminicsäuren
DK0472708T3 (da) Fremgangsmåde til fremstilling af ikke-infektiøst blodplasma
ES8304431A1 (es) "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa".
DK373489D0 (da) Rekombinante hybrid-partikler med morphologiske egenskaber svarende til antigenet hbsag og omfattende en immunogen sekvens, der inducerer neutraliserende antistoffer rettet mod hiv-retrovirus eller som kan genkendes af saadanne antistoffer, samt vaccine paa basis af saadanne partikler
DK78990A (da) Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza
IT8621230A1 (it) Policarbonati ramificati contenenti acidi alifatici policarbossilici o loro derivati e procedimento per la loro preparazione
AU3876793A (en) Process for the inactivation of viruses in preparations of proteins
DK211189A (da) Fremgangsmaade til fremstilling af 5-chlor-3-chlorsulfonyl-2-thiophencarboxylsyreestere
FI914673L (fi) Peptider, som reagerar immunokemiskt med antikroppar mot hepatitis icke-a, icke-b-virus.
ATE164594T1 (de) Verfahren zur extraktion und reinigung von alpha- 1-antitrypsin (alpha 1-pi) aus cohnischer fraktion iv-1
DK0841954T3 (da) Fremgangsmåde til fremstilling af et virussikkert, terapeutisk, biologisk apparat
DK0589348T3 (da) Fremgangsmåde til immunkemisk kvantificering af inaktiverede, immunreaktive antigener
FI930519A7 (fi) Peptiidejä HIV-viruksen aiheuttaman infektion torjumiseksi sekä menete lmä niiden käyttämiseksi